Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 5/20 | 0.49 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.43 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.43 |
| ▸ | IGF2R | P11717 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 4/20 | 0.42 |
| ▸ | AMY2A | P04746 | 4/20 | 0.42 |
| ▸ | MGAM | O43451 | 2/20 | 0.42 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | FGF1 | P05230 | 1/20 | 0.42 |
| ▸ | FGF2 | P09038 | 1/20 | 0.42 |
| ▸ | VEGFA | P15692 | 1/20 | 0.42 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12502058 | 0.99 | LGALS8 (0.48) | LGALS8LGALS3LGALS4IGF2RGAA | |
| SCHEMBL3931901 | 0.89 | LGALS8 (0.43) | LGALS8LGALS3LGALS4IGF2RAMY2A | |
| SCHEMBL11725244 | 0.89 | LGALS8 (0.43) | LGALS8LGALS3LGALS4IGF2RGAA | |
| SCHEMBL8468755 | 0.87 | LGALS8 (0.52) | LGALS8LGALS3LGALS4GAAAMY2A | |
| SCHEMBL2237219 | 0.87 | LGALS8 (0.49) | LGALS8LGALS3LGALS4GAAAMY2A | |
| SCHEMBL107662 | 0.86 | LGALS8 (0.45) | LGALS8LGALS3LGALS4IGF2RGAA | |
| SCHEMBL17767392 | 0.85 | LGALS8 (0.56) | LGALS8LGALS3LGALS4GAAAMY2A | |
| Water SCHEMBL15229271 | 0.85 | LGALS8 (0.44) | LGALS8LGALS3LGALS4GAAAMY2A | |
| SCHEMBL5395795 | 0.85 | LGALS8 (0.49) | LGALS8LGALS3LGALS4GAAAMY2A | |
| SCHEMBL17767386 | 0.84 | LGALS8 (0.46) | LGALS8LGALS3LGALS4GAAAMY2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024069644-A1 | A PHARMACEUTICALLY ACCEPTABLE FERRIC CARBOXYMALTOSE AND PREPARATION THEREOF | WEST BENGAL CHEMICAL INDUSTRIES LIMITED (IN) | 2024-04-04 | — | — | WO | claimed |
| CN-117756951-A | Iron carboxyl maltose refining process capable of controlling iron carrying amount | 苏州大学 | 2024-03-26 | — | — | CN | claimed |
| US-11752210-B2 | Sensitizing composition using electromagnetic waves for thermal therapy of cancers, and cancer therapy using same | JINIS CO., LTD. (KR) | 2023-09-12 | — | — | US | claimed |
| US-20230079782-A1 | SENSITIZING COMPOSITION USING ELECTROMAGNETIC WAVES FOR THERMAL THERAPY OF CANCERS, AND CANCER THERAPY USING SAME | JINIS CO., LTD. (KR) | 2023-03-16 | — | — | US | claimed |
| CN-113004429-B | Refining method of carboxyl ferric maltose | 金陵药业股份有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-115403675-A | Complexing and refining process of ferric carboxymaltose | 滨州学院 | 2022-11-29 | — | — | CN | claimed |
| CN-115322265-A | Carboxyl maltose controlled oxidation and purification process | 滨州学院 | 2022-11-11 | — | — | CN | claimed |
| US-20210236637-A1 | SENSITIZING COMPOSITION USING ELECTROMAGNETIC WAVES FOR THERMAL THERAPY OF CANCERS, AND CANCER THERAPY USING SAME | JINIS CO., LTD. (KR) | 2021-08-05 | — | — | US | claimed |
| WO-2021127642-A1 | SELECTIVE VALORIZATION OF BIOMASS SUGARS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-06-24 | — | — | WO | claimed |
| CN-113004429-A | Refining method of carboxyl ferric maltose | 金陵药业股份有限公司 | 2021-06-22 | — | — | CN | claimed |
| EP-2531097-B1 | METHODS AND DEVICES FOR REDUCING TRANSFUSIONS DURING OR AFTER SURGERY AND FOR IMPROVING QUALITY OF LIFE AND FUNCTION IN CHRONIC DISEASE | ACCUMEN INC (US) | 2020-05-06 | — | — | EP | claimed |
| EP-3212182-B1 | TREATMENT OR PREVENTION OF ANAEMIA IN PREGNANT NON-HUMAN MAMMALS AND OFFSPRING | PHARMACOSMOS HOLDING AS (DK) | 2019-06-26 | — | — | EP | claimed |
| US-20180147234-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF FIBROMYALGIA | AMERICAN REGENT, INC. | 2018-05-31 | — | — | US | claimed |
| US-20160310594-A1 | SENSITIZING COMPOSITION USING ELECTROMAGNETIC WAVES FOR THERMAL THERAPY OF CANCERS, AND CANCER THERAPY USING SAME | JINIS CO., LTD. (KR) | 2016-10-27 | — | — | US | claimed |
| EP-3058949-A1 | SENSITIZING COMPOSITION USING ELECTROMAGNETIC WAVES FOR THERMAL THERAPY OF CANCERS, AND CANCER THERAPY USING SAME | Jinis Co., Ltd. (KR) | 2016-08-24 | — | — | EP | claimed |
| EP-4392045-A1 | IRON COMPOSITIONS AND METHODS OF MAKING AND USING THEM | American Regent, Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| US-20240207411-A1 | LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS | SEAPORT THERAPEUTICS, INC. | 2024-06-27 | — | — | US | disclosed |
| US-20100266644-A1 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | LUITPOLD PHARMACEUTICALS, INC. (US) | 2010-10-21 | — | — | US | disclosed |
| US-7754702-B2 | complexed with iron; bioavailability; anemia | LUITPOLD PHARMACEUTICALS, INC. (US) | 2010-07-13 | — | — | US | disclosed |
| US-20070161600-A1 | complexed with iron; bioavailability; anemia | LUITPOLD PHARMACEUTICALS, INC. (US) | 2007-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240207411-A1 | LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS | LIPA, MALT1, SGMS1 | LGALS8 928/4885LGALS3 583/4885LGALS4 887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.